source
- Crown Biosciences remains independent after $204 million Adicon acquisition collapsesCrown Biosciences, a contract research organization, will continue operating on its own after a planned sale to China's Adicon did not close. The parties announced on Nov 16 that they were ending…
- Quanterix CEO Everett Cunningham resigns after ten months, interim leader appointedQuanterix announced that Everett Cunningham will leave his role as president and chief executive officer after serving less than a year. The company said he will step down to pursue another opportu…